CVS Pharmacy, the retail division of CVS Health, is America's leading retail pharmacy with over 7,800 CVS/pharmacy and Longs Drugs stores. CVS Pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com.
Our more than 26,000 CVS pharmacists dispense prescriptions and provide services such as flu vaccinations as well as face-to-face patient counseling with respect to adherence to drug therapies, closing gaps in care, and more cost effective therapies. Our integrated pharmacy services model enables us to enhance access to care while helping to lower overall health care costs and improve health outcomes.
CVS Pharmacy is proud to be the first national pharmacy to end the sale of tobacco and the first pharmacy in the nation to receive the Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry.
The CVS Pharmacy ExtraCare Rewards Program has set the gold standard in loyalty programs and is the longest running in the drugstore space. CVS Pharmacy offers a wide assortment of merchandise, including over-the-counter medications and health essentials, beauty products and cosmetics, healthy snacks, photo finishing, seasonal merchandise, greeting cards and convenience items.
CVS Pharmacy is a division of CVS Health, a pharmacy innovation company helping people on their path to better health. By offering customers access to CVS/minute clinic, CVS/specialty and CVS/caremark, CVS Health is creating a unique integrated model that increases access to quality care, delivers better health outcomes and lowers overall health care costs. To learn more about CVS Pharmacy, visit www.cvs.com.
Closing share price
|FY, 2013||FY, 2014||FY, 2015||FY, 2016|
|$126.8 b||$139.4 b||$153.3 b||$177.5 b|
Revenue growth, %
Cost of goods sold
|$103 b||$114 b||$126.8 b||$148.7 b|
|$8 b||$8.8 b||$9.5 b||$10.3 b|
Pre tax profit
|$7.5 b||$7.7 b||$8.6 b||$8.6 b|
|$4.6 b||$4.6 b||$5.2 b||$5.3 b|
|Acquired Company||Date||Deal Size|
|Omnicare||May 21, 2015||$12.9 b|
|Navarro Discount Pharmacy||July 14, 2014|
|Coram Specialty Infusion||November 27, 2013||$2.1 b|